Under the partnership, Cigna will provide two years of medical claims data to ASAM and BrandeisUniversity researchers, who will analyze which treatment methodologies were the most effective.
Cigna expects researchers to complete the claims analysis this fall. The study will be funded in part by the National Institute on Alcohol Abuse and Alcoholism.
“We can drill down in the data and develop some predictive models,” William Lopez, MD, Cigna’s senior medical director, told Forbes. “This is a chronic disease and they may struggle with this for years. We can use this data to better manage [their care].”
More articles on payer issues:
UnitedHealthcare, Obstetrix contract impasse leaves patients without coverage
La. Medicaid program renamed ‘Healthy Louisiana’
BCBS of Illinois will stop accepting credit card payments
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
